Oct. 21 at 4:34 PM
$PRLD @pchr
1. Several potential upcoming milestones
2. Molecular glues / degraders seem to be regaining traction (i.e.
$CCCC decent results and several big pharma collaborations and
$GLUE recent huge partnership with Novartis with tons of $$$ (120M $ UPFRONT)
3.
$PRLD fusing PROTAC / molecular degraders with antibodies (great idea IMO with some likely specialized applications)
4. CEO purchased shares about a year ago
5. Generally drifting up with many other beat down biotechs.
6. Recent phantom spike up to
$1.91 (then full retrace) suggests wind of a (positive?) development a few weeks ago
7. My molecular dynamic simulation posted here a couple weeks ago (strong bias! LoL)